ACCESS DAXXIFY
Summary of public USPTO data
- Owner
- Revance Therapeutics, Inc.
- Status
- Live/Registered
- Serial number
- 98256425
- Registration number
- 8487196
- Filing date
- 2023-11-06
- Registration date
- 2026-10-06
- International classes
- 35
Goods and services
Class 35
- Business administration of patient reimbursement programs
- Business management of reimbursement programs for others